PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma.
Chen CL, Pan QZ, Zhao JJ, Wang Y, Li YQ, Wang QJ, Pan K, Weng DS, Jiang SS, Tang Y, Zhang XF, Zhang HX, Zhou ZQ, Zeng YX, Xia JC.
Chen CL, et al. Among authors: zhao jj.
Oncoimmunology. 2016 May 31;5(7):e1176653. doi: 10.1080/2162402X.2016.1176653. eCollection 2016 Jul.
Oncoimmunology. 2016.
PMID: 27622026
Free PMC article.